PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $46M
- YoY, 2025
- +22.4%
- 5-year CAGR
- +42.2%
- 10-year CAGR
- +84.8%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $46M | +22.4% |
| 2024 | $38M | +28.2% |
| 2023 | $29M | +21.0% |
| 2022 | $24M | +47.6% |
| 2021 | $16M | +107.6% |
| 2020 | $7.9M | −5.4% |
| 2019 | $8.4M | +20.7% |
| 2018 | $6.9M | +63.1% |
| 2017 | $4.2M | +99.1% |
| 2016 | $2.1M | +2,051.5% |
| 2015 | $99K | +135.7% |
| 2014 | $42K | — |